Published • loading... • Updated
Mercy Health Providers Laud Successful Pancreatic Cancer Breakthrough Medication
Summary by WPSD Local 6
4 Articles
4 Articles
WPSD Local 6Reposted by 
The Paducah Sun
The Paducah SunMercy Health providers laud successful pancreatic cancer breakthrough medication
“[Daraxonrasib] is a breakthrough, and it's potentially going to be used in other tumor types,” Director of Oncology William L. Skinner, M.D., said. “It's not only improving survival, but it's also improving quality of life.”
·Paducah, United States
Read Full Article
The U.S. Food and Drug Administration has approved the oral targeted drug daraxonrasib for advanced pancreatic cancer. This represents a breakthrough in the treatment of this highly lethal cancer.
B. The United States Food and Drug Administration has approved the drug DARACONARIB for the treatment of freakin' pancreas cancer patients after receiving chemotherapy, following the results of a clinical trial that has shown that the disease has been caused by the disease.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right2Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
